# Executive Recommendation Memo
## Re: Campaign Experiment — Launch / No Launch Decision

**To:** Senior Leadership & Product Teams  
**From:** Data & Analytics Team  
**Date:** June 18, 2026  
**Classification:** Internal — Confidential

---

## Executive Summary

We conducted a controlled A/B experiment involving **1,408 users** (693 Control, 715 Treatment) over a 30-day testing window to evaluate the impact of the new marketing campaign on user conversion metrics and overall revenue.

**Key Finding:** The Treatment campaign delivered a **statistically significant** boost to the Paid Conversion Rate, surging from 3.17% to 6.99% (a +120.28% net lift). Furthermore, all primary guardrail metrics remained safely within acceptable operational thresholds.

---

## Final Decision: 🚀 LAUNCH

---

## North Star Metric Performance

| Metric | Control | Treatment | Lift | Significant? |
| :--- | :--- | :--- | :--- | :--- |
| **Paid Conversion Rate** ⭐ | 3.17% | 6.99% | +120.28% | ✅ Yes ($p=0.0006$) |
| Avg Engagement Score | 57.02 | 62.93 | +10.36% | ✅ Yes |
| ARPU | ₹51.7493 | ₹53.8751 | +4.11% | ❌ No |
| Total Revenue (30d) | ₹35,862.28 | ₹38,520.71 | +7.41% | Directional |

---

## Supporting Metrics Summary

| Metric | Control | Treatment | Lift |
| :--- | :--- | :--- | :--- |
| Landing Page Visit Rate | 63.64% | 72.59% | +14.07% |
| Trial Start Rate | 25.11% | 29.09% | +15.86% |
| Onboarding Completion Rate | 15.58% | 21.26% | +36.41% |
| ARPPU | ₹1630.1036 | ₹770.4142 | -52.74% |
| Avg Days to Convert | 8.9 days | 6.4 days | -27.79% |

---

## Guardrail Analysis

All guardrail metrics were monitored against pre-established safety boundaries. A breach in any single metric would have triggered an automatic block on the launch.

| Guardrail | Control | Treatment | Threshold | Status |
| :--- | :--- | :--- | :--- | :--- |
| Refund Rate | 0.000 | 0.004 | ≤ 0.1 | ✅ PASS |
| Support Ticket Rate | 0.147 | 0.248 | ≤ 0.3 | ✅ PASS |
| Avg Days to Convert | 8.9 | 6.4 | ≤ 20 | ✅ PASS |

**Overall Guardrail Status: ✅ ALL PASSED**

---

## Segment Insights

* **Top Performing Region:** North region observed the highest conversion lift.
* **Top Performing Plan Type:** Free-tier users within the Treatment cohort showed the highest conversion rate.
* **Top Performing Platform:** Mobile devices outperformed desktop variants.

---

## Recommended Actions

### ✅ PROCEED WITH FULL LAUNCH

1. **Execute 100% Rollout:** Deploy the treatment campaign sitewide, as it met all safety guardrails and generated statistically significant conversion gains.
2. **Post-Launch KPI Monitoring:** Closely track Refund Rates and Support Ticket volumes on a weekly basis for the first month post-launch to ensure stability at scale.
3. **Targeted Optimization:** Prioritize user segments that demonstrated strong baseline affinity (Premium plan users and Desktop segments) for fast-tracked secondary campaigns.
4. **Monitor ARPPU Trends:** While overall ARPU trended upward, the dip in ARPPU should be audited quarterly to ensure long-term customer value remains sustainable.
5. **Onboarding Funnel Analysis:** Conduct a deep-dive into the onboarding flow to understand what drove the +36.41% improvement and apply those UX learnings to other funnels.

---

## Limitations & Risks

* The 30-day evaluation window may underrepresent users with longer multi-week consideration cycles.
* The experiment relied on a sample group; real-world scaling could introduce slight variances due to user novelty effects.
* Data pipelines missed the `device_type` property for 18 users, introducing a minor margin of error in segment calculations.
* Long-term retention dynamics remain unmeasured, meaning the final impact on Customer Lifetime Value (LTV) is currently unquantified.

---
*Prepared by: Business Intelligence & Data Analytics Team*
